Volume 4, Issue 2, Summer 2025

Articles

• 

  Cellular Therapy and Follicular Lymphoma: Where Do We Stand in 2025?

  Hadel El-Haddad, MD, Hannah Cherniawsky, MD, MSc

  5–10

  • PDF (en)
  • PDF (fr)
• 

  Front-line Treatment for Chronic Lymphocytic Leukemia in 2025: Finite Duration Versus Continuous Treatment

  Chathuri Abeyakoon, MD, Abi Vijenthira, MD

  12–20

  • PDF (en)
  • PDF (fr)
• 

  Intensive Versus Non-intensive Therapy for Patients with Newly Diagnosed Acute Myeloid Leukemia (AML)

  Karen W.L. Yee, MSc, MD, FRCPC

  22–35

  • PDF (en)
  • PDF (fr)
• 

  Management of Newly Diagnosed Primary Central Nervous System Lymphoma

  Diva Baggio, MD, Chris P. Fox, MBChB, FRCP, FRCPath, PhD

  37–46

  • PDF (en)
  • PDF (fr)
• 

  Concise Review of Chronic Myelomonocytic Leukemia in Canada in 2025

  Jacqueline Costello, MD

  48–53

  • PDF (en)
  • PDF (fr)